SCHEMBL196007

SCHEMBL196007

c1ccc2c(-c3ccc4ccccc4c3-c3cccc4ccccc34)cccc2c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 1/20 0.59
ALDH1A1 P00352 6/20 0.48
HSD17B10 Q99714 4/20 0.48
TSHR P16473 2/20 0.48
CYP2A6 P11509 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
MAPT P10636 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
DHFR P00374 1/20 0.44
CES1 P23141 1/20 0.44
HPRT1 P00492 1/20 0.44
ANPEP P15144 1/20 0.44
GPR84 Q9NQS5 1/20 0.44
TYMP P19971 1/20 0.43
CYP1A2 P05177 3/20 0.41
HPGD P15428 3/20 0.41
HIF1A Q16665 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29787010 1.00 DNMT1 (0.59) DNMT1ALDH1A1HSD17B10TSHRCYP2A6
SCHEMBL29410608 1.00 DNMT1 (0.59) DNMT1ALDH1A1HSD17B10TSHRCYP2A6
SCHEMBL31307687 0.98 DNMT1 (0.57) DNMT1ALDH1A1HSD17B10TSHRCYP2A6
SCHEMBL29810649 0.98 DNMT1 (0.57) DNMT1ALDH1A1HSD17B10TSHRCYP2A6
SCHEMBL25401765 0.94 HPRT1 (0.56) DNMT1ALDH1A1HSD17B10TSHRCYP2A6
SCHEMBL30692007 0.93 DNMT1 (0.61) DNMT1ALDH1A1HSD17B10TSHRCYP2A6
SCHEMBL30022344 0.92 DNMT1 (0.56) DNMT1ALDH1A1HSD17B10TSHRCYP2A6
SCHEMBL30021528 0.92 HPRT1 (0.54) DNMT1ALDH1A1HSD17B10TSHRCYP2A6
SCHEMBL25403069 0.92 DNMT1 (0.56) DNMT1ALDH1A1HSD17B10TSHRCYP2A6
SCHEMBL30022625 0.92 DNMT1 (0.56) DNMT1ALDH1A1HSD17B10TSHRCYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 509 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3262055-B1 WATER SOLUBLE FLUORESCENT OR COLORED DYES COMPRISING CONJUGATING GROUPS SONY GROUP CORP (JP) 2026-04-22 EP claimed
EP-4137818-B1 USE OF DIVALENT METALS FOR ENHANCEMENT OF FLUORESCENT SIGNALS SONY GROUP CORP (JP) 2025-12-10 EP claimed
EP-4590340-A1 POLYMERS WITH STEROIDS OR VITAMINS Sony Group Corporation (JP) 2025-07-30 EP claimed
EP-4590341-A1 POLYMERS WITH DUAL THERAPEUTIC AGENTS Sony Group Corporation (JP) 2025-07-30 EP claimed
EP-3440136-B1 ULTRA BRIGHT DIMERIC OR POLYMERIC DYES WITH SPACING LINKER GROUPS SONY GROUP CORP (JP) 2025-07-23 EP claimed
US-12359071-B2 Polymeric tandem dyes with linker groups Sony Group Corporation (JP) 2025-07-15 US claimed
WO-2025047293-A1 COMPOUND, DETECTION SYSTEM, AND MEASUREMENT DEVICE ソニーグループ株式会社 2025-03-06 WO claimed
US-20250009786-A1 AUTOMATED SYNTHESIS OF POLYMERIC DUAL DRUGS Sony Group Corporation (JP) 2025-01-09 US claimed
US-20250009898-A1 PYRROLOBENZODIAZEPINE CONJUGATES FOR CANCER TREATMENT SONY GROUP CORP (JP) 2025-01-09 US claimed
US-20240294767-A1 POLYMERIC TANDEM DYES WITH LINKER GROUPS SONY GROUP CORP (JP) 2024-09-05 US claimed
WO-2017197144-A1 ULTRA BRIGHT DIMERIC OR POLYMERIC DYES SONY CORPORATION (JP) 2017-11-16 WO claimed
WO-2017196954-A1 ULTRA BRIGHT POLYMERIC DYES WITH PEPTIDE BACKBONES SONY CORPORATION (JP) 2017-11-16 WO claimed
WO-2017177065-A2 ULTRA BRIGHT DIMERIC OR POLYMERIC DYES WITH SPACING LINKER GROUPS SONY CORPORATION (JP) 2017-10-12 WO claimed
WO-2017173348-A1 ULTRA BRIGHT DIMERIC OR POLYMERIC DYES WITH RIGID SPACING GROUPS SONY CORPORATION (JP) 2017-10-05 WO claimed
WO-2017173355-A1 ULTRA BRIGHT DIMERIC OR POLYMERIC DYES SONY CORPORATION (JP) 2017-10-05 WO claimed
EP-2959520-B1 OPTOELECTRONIC COMPONENT HELIATEK GMBH (DE) 2017-02-01 EP claimed
WO-2016183185-A1 ULTRA BRIGHT DIMERIC OR POLYMERIC DYES SONY CORPORATION (JP) 2016-11-17 WO claimed
US-7423133-B2 Fluorescent glycosides and methods for their use THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2008-09-09 US claimed
US-20040215012-A1 FLUORESCENT GLYCOSIDES AND METHODS FOR THEIR USE THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 2004-10-28 US claimed
WO-2004019002-A2 FLUORESCENT GLYCOSIDES AND METHODS FOR THEIR USE THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2004-03-04 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12359071-B2 Polymeric tandem dyes with linker groups CHRM1, IK, TMT1A DNMT1 826/4885ALDH1A1 1531/4885HSD17B10 4709/4885
US-20250009898-A1 PYRROLOBENZODIAZEPINE CONJUGATES FOR CANCER TREATMENT CHRM1, TPD52L2, H1-3 DNMT1 586/4885ALDH1A1 1901/4885HSD17B10 4468/4885
US-20250009786-A1 AUTOMATED SYNTHESIS OF POLYMERIC DUAL DRUGS CHRM1, CHRM2, H1-0 DNMT1 1640/4885ALDH1A1 1723/4885HSD17B10 4385/4885
US-20240294767-A1 POLYMERIC TANDEM DYES WITH LINKER GROUPS CHRM1, IK, TMT1A DNMT1 826/4885ALDH1A1 1531/4885HSD17B10 4709/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.